REXAHN PHARMACEUTICALS, INC. Business Operations Contracts & Agreements
13 Contracts & Agreements
- Agency Agreements (2 contracts)
- Collaboration Agreements (5)
- Indemnification Agreements (1)
- Sales Agreements (2)
- Services Agreements (1)
- Termination Agreements (1)
- Voting Agreements (1)
- License and Collaboration Agreement dated as of November 6, 2022 by and between Ocuphire Pharma, Inc. and Famy (Filed With SEC on November 7, 2022)
- Placement Agency Agreement, dated as of June 4, 2021, by and between Ocuphire Pharma, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on June 7, 2021)
- Placement Agency Agreement, dated as of June 4, 2021, by and between Ocuphire Pharma, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on June 4, 2021)
- Capital on Demand Sales Agreement, dated March 11, 2021 between Ocuphire Pharma, Inc. and JonesTrading Institutional Services LLC (Filed With SEC on March 11, 2021)
- Form of Indemnification Agreement (Filed With SEC on July 6, 2020)
- Form of Ocuphire Voting Agreement, by and among Ocuphire, Rexahn and certain stockholders of Ocuphire (Filed With SEC on June 19, 2020)
- Amendment No. 2 to Collaboration and License Agreement, dated as of March 10, 2020 between BioSense Global LLC and Rexahn Pharmaceuticals, Inc (Filed With SEC on May 7, 2020)
- Amendment No. 1 to Collaboration and License Agreement (Filed With SEC on August 29, 2019)
- Collaboration and License Agreement, dated as of February 25, 2019, between BioSense Global LLC and Rexahn Pharmaceuticals, Inc (Filed With SEC on August 7, 2019)
- Clinical Trial Collaboration and Supply Agreement, dated August 13, 2018, by and between Merck Sharp & Dohme B.V., and Rexahn Pharmaceuticals, Inc (Filed With SEC on November 2, 2018)
- At Market Issuance Sales Agreement, dated March 16, 2015, by and between Rexahn Pharmaceuticals, Inc. and MLV & CO. LLC (Filed With SEC on March 16, 2015)
- Financial Advisory Services Agreement, dated February 12, 2010, by and Between the Company and Garden State Securities Inc (Filed With SEC on August 16, 2010)
- Form of Termination and Release Agreement dated May 17, 2010 (Filed With SEC on May 21, 2010)
